| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 40,573 | 38,829 | 42,764 | 54,081 | | Cost of Revenue | 30,541 | 27,929 | 31,628 | 37,766 | | | Gross Profit | 10,032 | 10,900 | 11,136 | 16,315 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,353 | 13,723 | 13,190 | 15,493 | | Non Recurring |
-
| 1,154 | 4,106 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,321) | (3,977) | (6,160) | 822 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (388) | 911 | (1,751) | 1,034 | | Earnings Before Interest And Taxes | (4,709) | (3,066) | (7,911) | 1,856 | | Interest Expense |
-
| 844 | (396) | 214 | | Income Before Tax | (4,709) | (3,910) | (7,515) | 1,642 | | Income Tax Expense | (1,578) | (1,682) | (2,765) | 507 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,131) | (2,228) | (4,750) | 1,135 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,131) | (2,228) | (4,750) | 1,135 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,131) | ($2,228) | ($4,750) | $1,135 |
|
0.09% Nasdaq 
Income Statement
